Resources

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (September 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

Presentations from the 2019 MS Summit

View Presentations here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (June 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (March 2019)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition*, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad and sustained access to MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (April 2017)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Download here

The use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (March 2017)

The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Download here

MS Coalition Brochure (January 2012)

The Multiple Sclerosis Coalition (MSC) was founded in 2005 by three independent multiple sclerosis (MS) organizations in an effort to work together to benefit individuals with MS. Since that time, the MSC has grown to nine member organizations, all of whom provide critical MS programs and services.    Download here

Follow us on Twitter

TwitterFollow

MS Coalition
Retweet on TwitterMS Coalition Retweeted
iConquerMSiConquerMS@iConquerMS·
13 May 2021

How well and how safely do the #COVID_19 vaccines work in people with #MS? Join the COVER-MS study and help answer that important question! Learn more and sign up here: http://bit.ly/cover-ms

Reply on Twitter 1392832885653049346Retweet on Twitter 13928328856530493462Like on Twitter 13928328856530493465Twitter 1392832885653049346
Retweet on TwitterMS Coalition Retweeted
UnitedSpinalUnited Spinal@UnitedSpinal·
16 May 2021

Authentic representation of #disability in children's books is important! Check out Garrison Redd's #book "Bobby's New Adventure at a New School" to see how Bobby navigates going to school in a #wheelchair for the first time. Click here to order: https://amzn.to/3hucbo8

Reply on Twitter 1394059205259284481Retweet on Twitter 13940592052592844813Like on Twitter 13940592052592844815Twitter 1394059205259284481
Load More...